Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale M&A Activity 2021

Feb 23, 2021

1671_mrq_2021-02-23_cf5253f0-da55-42d4-be75-77d62140f089.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0263Q

Societe Generale SA

23 February 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.000304635 ordinary shares
Date of dealing 22/02/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 796,086 0.62 1,589 0.00
(2) Derivatives (other than options) 1,428 0.00 8,131 0.01
(3) Options and agreements to purchase/sell 0 0.00 0 0.00
Total *2,430,970 *1.89 9,720 0.01

* Include the holding of shares 1,633,456 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 100 225.27
Purchase 100 225.88
Purchase 11 225.14
Purchase 100 224.89
Purchase 100 224.79
Purchase 100 224.96
Purchase 267 224.9
Purchase 100 225.07
Purchase 1 224.94
Purchase 99 224.94
Purchase 100 224.78
Purchase 9 225.02
Purchase 91 225.02
Purchase 57 224.68
Purchase 23 224.68
Purchase 20 224.68
Purchase 1 224.95
Purchase 1 224.95
Purchase 100 224.9
Purchase 1,520 224.9
Sale 113,991 224.9
Sale 1 224.998
Sale 1 224.998
Sale 2 225.798
Sale 2 225.248
Sale 2 224.858
Sale 2 224.858
Sale 1 224.748
Sale 2 224.718
Sale 2 225.118
Sale 2 225.388
Sale 2 225.728
Sale 2 224.958
Sale 2 224.818
Sale 1 225.008
Sale 2 225.288
Sale 2 224.928
Sale 2 225.238
Sale 2 225.368
Sale 2 224.838
Sale 2 225.218
Sale 3 224.778
Sale 2 225.758
Sale 2 225.208
Sale 2 224.998
Sale 2 224.678
Sale 2 225.148
Sale 2 224.908
Sale 2 225.288
Sale 2 225.418
Sale 2 225.658
Sale 2 224.958
Sale 1 224.958
Sale 2 224.808
Sale 2 225.318
Sale 2 224.858
Sale 2 225.168
Sale 2 225.208
Sale 2 224.998
Sale 2 224.918
Sale 2 225.518
Sale 2 224.858
Sale 2 225.218
Sale 2 225.718
Sale 1 225.328
Sale 2 225.688
Sale 2 225.058
Sale 2 225.508
Sale 2 224.998
Sale 2 225.108
Sale 2 224.948
Sale 2 225.348
Sale 2 225.268
Sale 2 224.968
Sale 2 224.598
Sale 2 225.328
Sale 3 224.398
Sale 2 224.658
Sale 1 225.048
Sale 2 225.388
Sale 2 224.718
Sale 2 225.298
Sale 2 224.798
Sale 2 225.008
Sale 1 225.018
Sale 2 224.808
Sale 2 224.758
Sale 2 225.268
Sale 2 225.238
Sale 2 225.998
Sale 3 225.248
Sale 2 225.288
Sale 2 225.798
Sale 2 224.958
Sale 2 224.958
Sale 2 225.498
Sale 2 224.998
Sale 1 224.708
Sale 1 225.008
Sale 2 225.218
Sale 1 225.208
Sale 1 224.708
Sale 2 225.088
Sale 2 225.028
Sale 2 225.208
Sale 2 225.248
Sale 2 225.158
Sale 2 225.348
Sale 2 225.198
Sale 2 224.978
Sale 2 225.048
Sale 2 224.858
Sale 2 225.058
Sale 2 225.098
Sale 2 225.778
Sale 2 225.368
Sale 100 224.9
Total Purchases 2,900
Total Sales 114,272

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)
Euro Medium Term Note Increased long 10 224.90

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure 23/02/2021
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEKXLBLFLLLBBX